KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $217,000 | +17.3% | 30,000 | 0.0% | 0.03% | -5.6% |
| Q1 2017 | $185,000 | +5.1% | 30,000 | 0.0% | 0.04% | +125.0% |
| Q4 2016 | $176,000 | +10.7% | 30,000 | 0.0% | 0.02% | -40.7% |
| Q3 2016 | $159,000 | -20.1% | 30,000 | 0.0% | 0.03% | -38.6% |
| Q2 2016 | $199,000 | +42.1% | 30,000 | 0.0% | 0.04% | +33.3% |
| Q1 2016 | $140,000 | +68.7% | 30,000 | +81.8% | 0.03% | +73.7% |
| Q4 2015 | $83,000 | – | 16,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |